(19)
(11) EP 2 249 646 A1

(12)

(43) Date of publication:
17.11.2010 Bulletin 2010/46

(21) Application number: 09707940.4

(22) Date of filing: 05.02.2009
(51) International Patent Classification (IPC): 
A01N 43/42(2006.01)
(86) International application number:
PCT/US2009/033132
(87) International publication number:
WO 2009/100169 (13.08.2009 Gazette 2009/33)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA RS

(30) Priority: 06.02.2008 US 26574

(71) Applicant: Glaxo Group Limited
Greenford, Middlesex UB6 0NN (GB)

(72) Inventors:
  • CALLAHAN, James, Francis
    King Of Prussia PA 19406 (US)
  • LI, Tindy
    King Of Prussia PA 19406 (US)
  • WAN, Zehong
    Shanghai (CN)
  • YAN, Hongxing
    King Of Prussia PA 19406 (US)

(74) Representative: Cooke, Tracey 
GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road
GB-Brentford, Middlesex TW8 9GS
GB-Brentford, Middlesex TW8 9GS (GB)

   


(54) DUAL PHARMACOPHORES - PDE4-MUSCARINIC ANTAGONISTICS